Stereotaxis (STXS) Shares Outstanding (Weighted Average) (2010 - 2026)

Stereotaxis (STXS) reported Shares Outstanding (Weighted Average) of $98.9 million for Q1 2026, up 12.67% year-over-year from $87.8 million in Q1 2025, and up 8.72% quarter-over-quarter from $91.0 million in Q4 2025.

Stereotaxis (STXS) Shares Outstanding (Weighted Average) (2010 - 2026) Analysis & Trends

Stereotaxis (STXS) has 17 years of Shares Outstanding (Weighted Average) data on file, last reported at $98.9 million in Q1 2026.

  • Shares Outstanding (Weighted Average) for Q1 2026 came in at $98.9 million, up 12.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $98.9 million (up 12.67% YoY), and the FY2025 annual result was $91.0 million, up 6.78% from the prior year.
  • Shares Outstanding (Weighted Average) grew to $98.9 million in Q1 2026 per STXS's latest filing, from $91.0 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $98.9 million in Q1 2026 and troughed at $75.9 million in Q1 2022.
  • A 5-year average of $83.1 million and a median of $83.5 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
  • The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Weighted Average) rose 0.66% in 2022, then increased 12.67% in 2026.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $76.1 million in 2022, then advanced by 6.1% to $80.7 million in 2023, then rose by 5.55% to $85.2 million in 2024, then increased by 6.78% to $91.0 million in 2025, then advanced by 8.72% to $98.9 million in 2026.
  • Business Quant data shows STXS's Shares Outstanding (Weighted Average) at $98.9 million in Q1 2026, $91.0 million in Q4 2025, and $89.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn 354.90 Mn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn 283.14 Mn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn 819.00 Mn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 145.34 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 72.00 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn 174.20 Mn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn 195.40 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn 71.43 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn 515.00 Mn
10 Stereotaxis 180.48 Mn 165.86 Mn 3.79 Mn 98.89 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 98.89 Mn
Dec 31, 2025 90.96 Mn
Sep 30, 2025 89.26 Mn
Jun 30, 2025 87.86 Mn
Mar 31, 2025 87.77 Mn
Dec 31, 2024 85.18 Mn
Sep 30, 2024 84.63 Mn
Jun 30, 2024 84.03 Mn
Mar 31, 2024 83.48 Mn
Dec 31, 2023 80.70 Mn
Sep 30, 2023 80.03 Mn
Jun 30, 2023 78.79 Mn
Mar 31, 2023 76.50 Mn
Dec 31, 2022 76.06 Mn
Sep 30, 2022 75.98 Mn
Jun 30, 2022 75.92 Mn
Mar 31, 2022 75.88 Mn
Dec 31, 2021 75.56 Mn
Sep 30, 2021 75.48 Mn
Jun 30, 2021 75.36 Mn